Showing results (241-250 of 16,630) with videos related to
Sort By:
Pageof 1,663
Cancer Letters|April 30, 2016
Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patientsJi-Ye Yin, Xi Li, Xiang-Ping Li, et al.Cancer Letters|May 3, 2016
Metabolic alterations and drug sensitivity of tyrosine kinase inhibitor resistant leukemia cells with a FLT3/ITD mutationAmin Huang, Huai-Qiang Ju, Kaiyan Liu, et al.Cancer Letters|March 19, 2016
B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cellsYanrui Sun, Xi Yang, Min Liu, et al.Cancer Letters|April 1, 1989
Effects of urinary transferrin and ornithine decarboxylase-inducing fraction on rat bladder carcinogenesisS Noguchi, Y Yura, O Hayashi, et al.Cancer Letters|February 23, 2016
Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancerShiv Ram Krishn, Sukhwinder Kaur, Lynette M Smith, et al.Cancer Letters|February 16, 2016
Mesenchymal stem cells exhibit resistance to topoisomerase inhibitionNils H Nicolay, Alexander Rühle, Ramon Lopez Perez, et al.Cancer Letters|October 25, 2017
Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trialKakoli Das, Masataka Taguri, Hiroshi Imamura, et al.Cancer Letters|October 25, 2017
Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180Kazuhiro Koikawa, Kenoki Ohuchida, Shin Takesue, et al.Cancer Letters|October 12, 2017
The use of natural compounds for the targeting and chemoprevention of ovarian cancerFrancesca Pistollato, Ruben Calderón Iglesias, Roberto Ruiz, et al.Cancer Letters|April 30, 2022
Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activityLuyan Shen, Yefei Xiao, Chaoting Zhang, et al.Pageof 1,663